• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Fenfluramines, idiopathic pulmonary primary hypertension and cardiac valve disorders: facts and artifacts.

作者信息

Tellier P

机构信息

Centre de Médecine Nucléaire de l'Artois (CMNA), Clinique Sainte-Catherine, 62223 Arras, France.

出版信息

Ann Med Interne (Paris). 2001 Nov;152(7):429-36.

PMID:11965083
Abstract

The fenfluramines saga began in 1963 and ended in 1997. Fenfluramines are anorexigenic agents recommended, in April 1996, for the long-term treatment of obesity in USA, before being suddenly withdrawn from the market in September 1997. Over 34 years, about 60 million people were exposed to these drugs worldwide, mainly in Europe. The aim of this critical review is not to attempt to rehabilitate these appetite suppressants but to launch a plea for a more rational and rigorous approach to what might be called objective medical knowledge. Idiopathic primary pulmonary hypertension and cardiac valve disorders which have been both associated with fenfluramines have in common many puzzling features. The metamorphosis of facts into artifacts is only a hypothesis, but seems conceivable from a scientific point of view. Medicine is not only an art, it is also a science, which, like the others, implies adhesion to certain fundamental rules, such as refutation or verification of all experimental results by rigorous and standardized methods, before considering them as established facts. Firstly, a single study, moreover a case-control study like the International Primary Pulmonary Hypertension Study, is not sufficient to establish a causal relationship between exposure to appetite-suppressants and idiopathic pulmonary hypertension, because of the numerous biases which characterize even the best analytical research. Secondly, Doppler-echocardiography cannot be considered as a laboratory test, because of the poor interoperator reproducibility observed in obese patients. The use of this technique in pharmaco-epidemiology implies standardized procedures concerning not only reading data, but also their acquisition, because of possible uncontrolled interactions between sonographers, patients and sophisticated machines. In the case of the fenfluramines saga, numerous methodological artifacts concerning acquisition, processing and interpretation of epidemiologic and echocardiographic data might have contributed to distortion of reality. Let us recall how Webster's dictionary defines artifact: "a spurious observation or result arising from preparatory or investigative procedures or any feature that is not naturally present but is a product of an extrinsic agent, method, or the like".

摘要

相似文献

1
Fenfluramines, idiopathic pulmonary primary hypertension and cardiac valve disorders: facts and artifacts.
Ann Med Interne (Paris). 2001 Nov;152(7):429-36.
2
[Appetite suppressants and heart valve disorders].[食欲抑制剂与心脏瓣膜疾病]
Arch Mal Coeur Vaiss. 1999 Sep;92(9):1213-9.
3
Benfluorex: increasing reports of valve disorders.苯氟雷司:关于瓣膜疾病的报告日益增多。
Prescrire Int. 2010 Feb;19(105):17.
4
Anorexigen-induced cardiac valvulopathy and female gender.食欲抑制剂所致心脏瓣膜病与女性性别。
Curr Womens Health Rep. 2003 Apr;3(2):116-25.
5
[Drug-clinics. The hue and cry over central appetite suppressants!].[药物诊所。对中枢性食欲抑制剂的强烈抗议!]
Rev Med Liege. 1997 Sep;52(9):613-5.
6
Benfluorex: negative data in France, but still on the market. Neuropsychiatric disorders, pulmonary hypertension and heart valve damage.苯氟雷司:在法国有负面数据,但仍在市场上销售。存在神经精神障碍、肺动脉高压和心脏瓣膜损害问题。
Prescrire Int. 2009 Jun;18(101):124.
7
Primary pulmonary hypertension and long-term use of appetite suppressants.
CMAJ. 1997 Jan 1;156(1):89-90, 93-4.
8
Brain serotonin neurotoxicity and primary pulmonary hypertension from fenfluramine and dexfenfluramine. A systematic review of the evidence.芬氟拉明和右芬氟拉明导致的脑血清素神经毒性与原发性肺动脉高压。证据的系统评价
JAMA. 1997 Aug 27;278(8):666-72.
9
[The French are wary of their drugs].法国人对他们的药品持谨慎态度。
Rev Med Suisse. 2011 May 25;7(296):1170-1.
10
Mitral valve disease associated with use of anorexigenic medications.
Ann Thorac Surg. 1998 Jan;65(1):298-9.

引用本文的文献

1
Cardiovascular effects of phentermine and topiramate: a new drug combination for the treatment of obesity.苯丁胺和托吡酯的心血管效应:一种用于治疗肥胖症的新型药物组合
J Hypertens. 2014 Jun;32(6):1178-88. doi: 10.1097/HJH.0000000000000145.
2
Pulmonary hypertension associated with use of phentermine.与使用苯丁胺相关的肺动脉高压。
Yonsei Med J. 2010 Nov;51(6):971-3. doi: 10.3349/ymj.2010.51.6..
3
Safety of drug therapies used for weight loss and treatment of obesity.用于减肥和肥胖症治疗的药物疗法的安全性。
Drug Saf. 2006;29(4):277-302. doi: 10.2165/00002018-200629040-00001.